Document:

Common Stock Exchange Agreement

 Exhibit 10.39 

EXECUTION COPY 

COMMON STOCK EXCHANGE AGREEMENT 

COMMON STOCK EXCHANGE AGREEMENT (the “Agreement”), dated as of April 15, 2010, by and among Primerica, Inc., a
Delaware corporation (the “Company”), Warburg Pincus LLC, a Delaware limited liability company (“Warburg LLC”), and Warburg Pincus & Co., a Delaware corporation (together with Warburg LLC,
“Warburg”). 
 WHEREAS, Primerica, Citigroup Insurance Holding Corporation, a Georgia corporation
(“CIHC”), Warburg Pincus Private Equity X, L.P., a Delaware limited partnership (“Warburg PE”), and Warburg Pincus X Partners, L.P., a Delaware limited partnership (together with Warburg PE, the “Original
Investor”), entered into that certain Securities Purchase Agreement, dated as of February 8, 2010 (the “Purchase Agreement”), pursuant to which CIHC agreed to sell to the Investor shares of common stock, par value
$0.01 per share, of the Company (“Common Stock”) and a Warrant (as defined in the Purchase Agreement); and 

WHEREAS, pursuant to Section 3.6 of the Purchase Agreement, the Company agreed to assist any member of the WP Group (as
defined below) in exchanging any of its shares of Common Stock for shares of non-voting common stock, par value $0.01 per share, of the Company (“Non-Voting Stock”) in accordance with the terms and subject to the conditions in the
Purchase Agreement. 
 NOW, THEREFORE, in consideration of the premises, and of the representations, warranties,
covenants and agreements set forth herein and other good and valuable consideration, the adequacy of which is hereby acknowledged, the parties agree as follows: 

ARTICLE I 

DEFINITIONS 

Section 1.1    Definitions. 

As used in this Agreement, 

“Affiliate” means, with respect to any person, any person directly or indirectly controlling, controlled by or under
common control with, such other person; provided that, with respect to Warburg, Affiliate shall not include any portfolio company of Warburg unless Warburg has provided confidential information of the Company to such portfolio company. For purposes
of this definition, “control” (including, with correlative meanings, the terms “controlled by” and “under common control with”) when used with respect to any person, means the possession, directly or indirectly, of the
power to cause the direction of management or policies of such person, whether through the ownership of voting securities by contract or otherwise. 

“Business Day” means any day except Saturday, Sunday and any day which shall be a legal holiday or a day on which
banking institutions in the State of New York generally are authorized or required by law or other governmental actions to close. 
  

 1 

 “Exchange” means the exchange by an Investor that is a member of the WP
Group of shares of Common Stock for shares of Non-Voting Stock pursuant to Article II of this Agreement. 

“Investor” shall have the meaning ascribed to it in the Purchase Agreement. 

“Liens” means any and all liens, charges, security interests, options, claims, mortgages, pledges, proxies, voting
trusts or agreements, obligations, understandings or arrangements or other restrictions on title or transfer of any nature whatsoever. 

“Person” means an individual or a corporation, limited liability company, partnership, joint venture, trust, estate,
unincorporated organization, association (including any group, organization, co-tenancy, plan, board, council or committee), government (including a country, state, county, or any other governmental or political subdivision, agency or
instrumentality thereof) or other entity (or series thereof). 
 “Securities Act” means the United States
Securities Act of 1933, as amended 
 “Transfer Agent” means the Person appointed from time to time by the
Company to act as registrar and transfer agent for the Common Stock. 
 “WP Group” means, collectively,
Warburg and any of their controlled Affiliates. 
 ARTICLE II 

EXCHANGE OF COMMON STOCK 

Section 2.1    Exchange of Shares of Common Stock. 

(a)    Subject to the other provisions of this Agreement and at the request of the Original Investor, any Investor
that is a member of the WP Group shall be entitled to exchange shares of Common Stock held by such member for an equal number of shares of Non-Voting Stock at any time and from time to time in accordance with the terms and conditions of this
Agreement. 
 (b)    The obligation of the Company to effect any Exchange pursuant to this Agreement shall
be subject to compliance with the terms and conditions of the Purchase Agreement, including the ownership and transfer restrictions set forth in Sections 3.6 and 4.2 thereof. 

(c)    An Exchange will be deemed to be effective as of the close of business on the date of receipt of an Exchange
Notice Package (as defined below) (the “Exchange Date”) and the Common Stock to be exchanged shall be deemed to be automatically cancelled on the books and records of the Company and such Common Stock shall have no further rights or
privileges and shall no longer be deemed to be outstanding common stock of the Company for any purpose from and after the close of business on the Exchange Date and the Non-Voting Stock to be issued in the Exchange shall be deemed to be
automatically issued on the books and records of the Company as of the close of business on the Exchange Date. 
  

 2 

 Section 2.2    Exchange Procedures. 

(a)    A member of the WP Group may exercise its right to exchange shares of Common Stock as set forth in
Section 2.1(a) by providing an irrevocable written notice of exchange from such member and the Original Investor, substantially in the form of Exhibit A hereto (the “Exchange Notice”), accompanied by (i) the stock
certificates representing the shares of Common Stock to be exchanged, endorsed in blank or accompanied by duly executed stock powers (or similar instruments of assignment), or, in the event the shares of Common Stock are issued in an uncertificated
form, evidence of electronic transfer of the shares of Common Stock to the account designated by the Company or the Transfer Agent following receipt of delivery instructions from the Company or the Transfer Agent, (ii) a certificate to the
Company signed by a manager, general partner or authorized person of such member of the WP Group stating that each of the representations and warranties contained in Section 3.1 is true and correct as of the Exchange Date and, (iii) to the
extent reasonably requested by the Transfer Agent and/or the Company, instructions and/or other instruments of transfer, in form and substance reasonably satisfactory to such Transfer Agent and/or the Company, as applicable, duly executed by such
member or such member’s duly authorized legal representative, with respect to the Common Stock to be exchanged (together, an “Exchange Notice Package”). 

(b)    Each Exchange Notice shall be delivered to the Company in accordance with Section 4.2 and shall be duly
executed by the Original Investor and by such member of the WP Group or such member’s duly authorized legal representative with respect to the Common Stock to be exchanged. 

(c)    As promptly as practicable following the surrender of the shares of Common Stock upon an Exchange in the
manner provided in this Article II, the Company shall deliver or cause to be delivered at the address set forth in the Exchange Notice, or if no such address is provided, at the principal executive offices of Warburg or such other address for such
member of the WP Group participating in an Exchange (“Exchanging Member”) as reflected in the share register of the Company certificates representing shares of Non-Voting Stock, or, in the event the shares of Non-Voting Stock are
issued in an uncertificated form, such other evidence of ownership. 
 Section
2.3    Expenses.  Each party hereto shall bear its own expenses in connection with the consummation of any of the transactions contemplated hereby, whether or not any such transaction is ultimately consummated.

 Section 2.4    Reservation of Non-Voting Stock.  The Company will at all times reserve
and keep available, out of its authorized capital stock, a sufficient number of shares of Non-Voting Stock for the purpose of providing for any Exchanges pursuant to this Article II. 

REPRESENTATIONS AND WARRANTIES 

Section 3.1    Representations and Warranties of the Exchanging Member.  As of any Exchange Date,
the following representations and warranties of the Exchanging Member shall be true and correct: 
  

 3 

 (a)    Title to Common Stock.  The Exchanging Member
possesses good and marketable title to the Common Stock to be exchanged and has full right to transfer the same as contemplated herein. Such shares of Common Stock are delivered free and clear of any and all Liens. 

(b)    Purchase for Investment.  The Exchanging Member acknowledges that the Non-Voting Stock has
not been registered under the Securities Act or under any state securities laws. The Exchanging Member (i) is acquiring the Non-Voting Stock pursuant to an exemption from registration under the Securities Act solely for investment with no
present intention to distribute any of the Non-Voting Stock to any person, (ii) will not sell or otherwise dispose of any of the Non-Voting Stock, except in compliance with the transfer restrictions set forth in Section 4.2 of the Purchase
Agreement, and subject to Section 3.6 and Section 4.5 of the Purchase Agreement, and the registration requirements or exemption provisions of the Securities Act and any other applicable securities laws, (iii) has such knowledge and
experience in financial and business matters and in investments of this type that it is capable of evaluating the merits and risks of its investment in the Non-Voting Stock and of making an informed investment decision and (iv) is an
institutional “accredited investor” (as that term is defined in Rule 501 of the Securities Act). 

(c)    The Exchanging Member agrees and acknowledges that the shares of Non-Voting Stock issuable hereunder will be
subject to restrictions on transfer pursuant to applicable securities laws, and that all certificates or other instruments representing the Non-Voting Stock subject to this Agreement or to the Purchase Agreement will bear a legend substantially to
the following effect: 
 “THE NON-VOTING COMMON STOCK REPRESENTED BY THIS INSTRUMENT HAS NOT BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933, AS AMENDED, OR SECURITIES LAWS OF ANY STATE AND MAY NOT BE TRANSFERRED, SOLD OR OTHERWISE DISPOSED OF EXCEPT WHILE A REGISTRATION STATEMENT RELATING THERETO IS IN EFFECT UNDER SUCH ACT AND APPLICABLE STATE SECURITIES LAWS OR
PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER SUCH ACT OR SUCH LAWS. 
 To the extent Section 4.2 of the Purchase Agreement is
applicable at the time of any relevant Exchange, such shares will also bear a legend substantially to the following effect: 

THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO TRANSFER AND OTHER RESTRICTIONS SET FORTH IN A SECURITIES PURCHASE
AGREEMENT, DATED AS OF FEBRUARY 8, 2010, COPIES OF WHICH ARE ON FILE WITH THE SECRETARY OF THE ISSUER.” 
 Upon request of the Exchanging
Member and receipt by the Company of an opinion of counsel reasonably satisfactory to the Company to the effect that such legend is no longer required under the Securities Act and applicable state laws, the Company shall promptly cause the first
provision of the legend to be removed from any certificate for any Non-Voting Stock to be so 
  

 4 

 
transferred and, upon the request of the Exchanging Member, the second provision of the legend shall be removed upon the expiration of such transfer and other restrictions set forth in the
Purchase Agreement. 
 Section 3.2    Representations and Warranties of the Company.  As
of any Exchange Date, the following representations and warranties of the Company shall be true and correct: 

(a)    Title to Non-Voting Stock.  Any shares of Non-Voting Stock to be issued upon exchange in
accordance with the provisions of Article II are duly and validly authorized and issued, fully paid and nonassessable and issued by the Company free from all taxes, liens and charges. None of the Non-Voting Stock to be issued upon exchange in
accordance with the provisions of Article II shall be subject to any outstanding option, warrant, call, or similar right of any other Person to acquire the same, and none of such Non-Voting Stock will be subject to any restriction on transfer
thereof except for restrictions imposed by applicable federal and state securities laws, pursuant to any agreement or action taken by the Exchanging Member or by the express terms of the Purchase Agreement. 

(b)    Board Approval.  The issuance of shares of Non-Voting Stock to be exchanged in accordance
with the provisions of Article II has been approved by the board of directors of the Company or a committee thereof pursuant to a resolution substantially in the form of Exhibit B hereto (with such changes as may be reasonably requested by
the Exchanging Member), which action shall be taken pursuant to the Company’s obligations to cooperate with the Exchanging Member to seek to structure such exchange to exempt it from Section 16 pursuant to Rule 16b-3 promulgated under the
Securities Exchange Act of 1934 (or any successor rule). 
 ARTICLE IV 

GENERAL PROVISIONS 

Section 4.1    Amendment. 

(a)    The conditions to each party’s obligation to consummate the transactions contemplated hereby are for the
sole benefit of such party and may be waived by such party in whole or in part to the extent permitted by applicable law. Except as otherwise expressly provided herein, any provision of this Agreement may be amended or waived and the observance
thereof may be amended or waived (either generally or in a particular instance and either retroactively or prospectively) only by the written consent of the applicable parties to this Agreement. No amendment or waiver of any provision of this
Agreement will be effective with respect to any party unless made in writing and signed by an officer of a duly authorized representative of such party. 

(b)    Any member of the WP Group that acquires Common Stock may be joined to this Agreement by execution of a
joinder in a form reasonably satisfactory to the Company. The joinder of any Person to this Agreement pursuant to and in accordance with the 

 

 5 

 
express provisions of this Agreement shall not be deemed an amendment or waiver of this Agreement. 

Section 4.2    Addresses and Notices.  Any notice, request, instruction or other document to be
given hereunder by any party to the other will be in writing and will be deemed to have been duly given (a) on the date of delivery if delivered personally or facsimile, upon confirmation of receipt, (b) on the first business day following
the date of dispatch if delivered by a recognized next-day courier service or (c) on the third business day following the date of mailing if delivered by registered or certified mail, return receipt requested, postage prepaid. All notices
hereunder shall be delivered as set forth below, or pursuant to such other instructions as may be designated in writing by the party to receive such notice; provided, that an Exchange Notice Package will only be effective when actually
received by the Company. 
 (a)    If to the Company, to: 

Primerica, Inc. 

3120 Breckinridge Blvd. 

Duluth, Georgia 30099 

Attn:    General Counsel 

Facsimile:  (770) 564-6216 

(b)    If to Warburg, to: 

Warburg Pincus LLC 

450 Lexington Avenue 

New York, New York 10017-3911 

Attn:    General Counsel 

Facsimile:  (212) 716-8626 

Section 4.3    Further Action.  The parties shall execute and deliver all documents, provide all
information and take or refrain from taking action as may be necessary or appropriate to achieve the purposes of this Agreement. 

Section 4.4    Binding Effect.  This Agreement shall be binding upon and inure to the benefit of
all of the parties and, to the extent permitted or required by this Agreement, their successors, executors, administrators, heirs, legal representatives and assigns. 

Section 4.5    Captions.  The article, section, paragraph and clause captions herein are for
convenience of reference only, do not constitute part of this Agreement and will not be deemed to limit or otherwise affect any of the provisions hereof. 

Section 4.6    Severability.  If any provision of this Agreement or the application thereof to any
person (including, the officers and directors of Warburg and the Company) or circumstance is determined by a court of competent jurisdiction to be invalid, void or unenforceable, the remaining provisions hereof, or the application of such provision
to persons or circumstances other than those as to which it has been held invalid or unenforceable, will remain in full force and effect and shall in no way be affected, impaired or invalidated thereby, 

 

 6 

 
so long as the economic or legal substance of the transactions contemplated hereby is not affected in any manner materially adverse to any party. Upon such determination, the parties shall
negotiate in good faith in an effort to agree upon a suitable and equitable substitute provision to effect the original intent of the parties. 

Section 4.7    Entire Agreement.  This Agreement and the Purchase Agreement constitute the entire
agreement, and supersede all other prior agreements, understandings, representations and warranties, both written and oral, between the parties, with respect to the subject matter hereof; and (b) this Agreement will not be assignable by
operation of law or otherwise (any attempted assignment in contravention hereof being null and void). In the event and to the extent that there shall be any conflict or inconsistency between the provisions of this Agreement and the provisions of the
Purchase Agreement with respect to an Exchange, this Agreement shall control, and with respect to any other conflict or inconsistency between the provisions of this Agreement and the provisions of the Purchase Agreement, the Purchase Agreement shall
control. For the purposes of clarity, the mechanics for the exchange of Non-Voting Stock into Common Stock are described in the Restated Certificate of Incorporation of the Company. 

Section 4.8    Waiver.  No failure by any party to insist upon the strict performance of any
covenant, duty, agreement or condition of this Agreement or to exercise any right or remedy consequent upon a breach thereof shall constitute waiver of any such breach of any other covenant, duty, agreement or condition. 

Section 4.9    Counterparts.  For the convenience of the parties hereto, this Agreement may be
executed in any number of separate counterparts, each such counterpart being deemed to be an original instrument, and all such counterparts will together constitute the same agreement. Executed signature pages to this Agreement may be delivered by
facsimile and such facsimiles will be deemed as sufficient as if actual signature pages had been delivered. 
 Section
4.10    Governing Law.  This Agreement will be governed by and construed in accordance with the laws of the State of Delaware applicable to contracts made and to be performed entirely within such State and
without regard to its conflict of laws principles. The parties hereby irrevocably and unconditionally consent to submit to the exclusive jurisdiction of the state and federal courts located in the State of Delaware for any actions, suits or
proceedings arising out of or relating to this Agreement and the transactions contemplated hereby. Each of the parties hereby agrees not to commence any such action, suit or proceeding other than before one of the above-named courts. 

Section 4.11    WAIVER OF JURY TRIAL.  TO THE FULLEST EXTENT PERMITTED BY LAW, EACH OF THE PARTIES
HERETO HEREBY IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATED TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY AND AGREE THAT ANY SUCH LEGAL PROCEEDING WILL INSTEAD BE TRIED IN A COURT
OF COMPETENT JURISDICTION BY A JUDGE SITTING WITHOUT A JURY. 
  

 7 

 [Remainder of Page Intentionally Left Blank] 

 

 8 

 IN WITNESS WHEREOF, the parties have caused this Agreement to be duly executed and
delivered, all as of the date first set forth above. 
  

					
	PRIMERICA, INC.
		
	By:	 	/s/ Peter W. Schneider
		 	Name:	 	Peter W. Schneider
		 	Title:	 	Executive Vice President and General Counsel

[SIGNATURE PAGE TO COMMON STOCK EXCHANGE
AGREEMENT] 

					
	WARBURG PINCUS LLC
		
	By:	 	/s/ Michael Martin
		 	Name:	 	Michael Martin
		 	Title:	 	Managing Director
	
	WARBURG PINCUS & CO.
		
	By:	 	/s/ Michael Martin
		 	Name:	 	Michael Martin
		 	Title:	 	Managing Director

[SIGNATURE PAGE TO COMMON STOCK EXCHANGE
AGREEMENT] 

 EXHIBIT A 

FORM OF 

NOTICE OF EXCHANGE 

Primerica, Inc. 
 3120 Breckinridge Road

 Duluth, Georgia 30099 
 Attention:
General Counsel 
 Fax: (770) 564-6216 

Reference is hereby made to the Common Stock Exchange Agreement, dated as of April [    ], 2010 (the
“Exchange Agreement”), among Primerica, Inc., Warburg Pincus LLC and Warburg Pincus & Co. Capitalized terms used but not defined herein have the meanings given to them in the Exchange Agreement. 

The undersigned member of the WP Group desires to exchange the number of shares of Common Stock set forth below. 

Legal Name of member of the WP Group:
                                         
                                         
                           

Address:
                                         
                                         
                                         
                                         

 Number of shares of Common Stock to be exchanged:
                                         
         
 The undersigned hereby (1) represents that the representations and warranties set
forth in Section 3.1 of the Exchange Agreement as to the undersigned, as the “Exchanging Member,” are true and correct, (2) exchanges such shares of Common Stock for shares of Non-Voting Stock, (3) irrevocably constitutes
and appoints any officer of the Company as its attorney, with full power of substitution, to exchange said Common Stock on the books of the Company for Non-Voting Stock on the books of the Company and (4) acknowledges and agrees that the terms
of the Exchange Agreement shall govern this Exchange. 
  

 A-1 

 IN WITNESS WHEREOF the undersigned, by authority duly given, has caused this Notice of
Exchange to be executed and delivered by the undersigned or by its duly authorized attorney. 
  

	
	
	  
	Name:

Dated:                        
                                         
    
 AGREED AND ACKNOWLEDGED BY THE 

ORIGINAL INVESTOR: 
 WARBURG PINCUS
PRIVATE EQUITY X, L.P. 
  

					
	By: Warburg Pincus X L.P., its general partner
	By: Warburg Pincus X LLC, its general partner
	By: Warburg Pincus Partners LLC, its sole member
	By: Warburg Pincus & Co., its managing member
		
	By:	 	 
		 	Name:	 	
		 	Title:	 	

 WARBURG PINCUS X PARTNERS, L.P. 

 

					
	By: Warburg Pincus X L.P., its general partner
	By: Warburg Pincus X LLC, its general partner
	By: Warburg Pincus Partners LLC, its sole member
	By: Warburg Pincus & Co., its managing member
		
	By:	 	 
		 	Name:	 	
		 	Title:	 	

  

 B-2Registration Rights Agreement

 Exhibit 10.40 

EXECUTION COPY 

REGISTRATION RIGHTS AGREEMENT 

by and among 

CITIGROUP INSURANCE HOLDING CORPORATION, 

WARBURG PINCUS PRIVATE EQUITY X, L.P., 

WARBURG PINCUS X PARTNERS, L.P. 

and 

PRIMERICA, INC. 

Dated as of April 7, 2010 

 TABLE OF CONTENTS 

 

							
		 		  		  	Page
			
	ARTICLE I	 	DEFINITIONS	  	1
		 	Section 1.1.	  	Certain Defined Terms	  	1
		 	Section 1.2.	  	Terms Generally	  	4
			
	ARTICLE II	 	REGISTRATION RIGHTS	  	5
		 	Section 2.1.	  	Piggyback Registrations	  	5
		 	Section 2.2.	  	Demand Registrations	  	6
		 	Section 2.3.	  	Holdback Agreements;	  	9
		 	Section 2.4.	  	Registration Procedures	  	9
		 	Section 2.5.	  	Restriction on Disposition of Registrable Securities	  	13
		 	Section 2.6.	  	Selection of Underwriters	  	13
		 	Section 2.7.	  	Registration Expenses	  	13
		 	Section 2.8.	  	Conversion of Other Securities	  	14
		 	Section 2.9.	  	Rule 144; Rule 144A	  	14
		 	Section 2.10.	  	Transfer of Registration Rights	  	14
		 	Section 2.11.	  	Free Writing Prospectuses	  	15
		 	Section 2.12.	  	Certain Additional Agreements	  	15
		 	Section 2.13	  	Certain Registration Rights	  	16
		 	Section 2.14.	  	Indemnification	  	16
			
	ARTICLE III	 	MISCELLANEOUS	  	20
		 	Section 3.1.	  	Other Activities; Nature of Holder Obligations	  	20
		 	Section 3.2.	  	Adjustments Affecting Registrable Securities	  	20
		 	Section 3.3.	  	Termination	  	21
		 	Section 3.4.	  	Amendment and Waiver	  	21
		 	Section 3.5.	  	Severability	  	21
		 	Section 3.6.	  	Entire Agreement	  	21
		 	Section 3.7.	  	Counterparts; Execution by Facsimile Signature	  	21
		 	Section 3.8.	  	Remedies	  	21
		 	Section 3.9.	  	Notices	  	22
		 	Section 3.10.	  	Governing Law; WAIVER OF JURY TRIAL	  	23
		 	Section 3.11.	  	Condition to Effectiveness for Warburg	  	23

  

 -i- 

 Index of Principal Terms 

 

			
	Defined Term	  	Section
		
	 Action
	  	1.1
	 Additional Warrant
	  	1.1
	 Affiliate
	  	1.1
	 Agreement
	  	1.1
	 Beneficial Ownership
	  	1.1
	 Business Day
	  	1.1
	 Citi
	  	Recitals
	 Citi Affiliated Group
	  	1.1
	Common Stock	  	Recitals
	 Company
	  	Recitals
	 Company Indemnitees
	  	2.14(b)
	 Company Subsidiaries
	  	1.1
	 Delay Period
	  	2.2(d)
	Demand Registration	  	2.2(b)
	Exchange Act	  	1.1
	 Full Cooperation
	  	1.1
	 Fully Marketed Underwritten Offering
	  	1.1
	 Governmental Entity
	  	1.1
	 Holder Indemnitees
	  	2.14(a)
	 Holders
	  	1.1
	indemnified party	  	2.14(c)
	 indemnifying party
	  	2.14(c)
	 Independent Contractor Representatives
	  	1.1
	 Initial Public Offering
	  	1.1
	 Inspectors
	  	2.4(j)
	 IPO S-1
	  	1.1
	 Issuer Free Writing Prospectus
	  	1.1
	 Law
	  	1.1
	 Losses
	  	2.14(a)
	 Non-Voting Stock
	  	Recitals
	 Person
	  	1.1
	Piggyback Registration	  	2.1(a)
	 Primerica
	  	Recitals
	 Primerica Records
	  	2.4(j)
	 Privilege
	  	1.1
	 Prospectus
	  	1.1
	 Purchase Agreement
	  	Recitals
	 Qualified IPO
	  	1.1
	 Registrable Securities
	  	1.1
	 Registration Statement
	  	1.1
	 Rule 144
	  	1.1

  

 -ii- 

			
	Rule 144A	  	1.1
	SEC	  	1.1
	Securities Act	  	1.1
	Selling Holder	  	1.1
	Shelf Registration Statement	  	2.2(a)
	Subsidiary	  	1.1
	Suspension Notice	  	2.4(f)
	transferee	  	2.10(a)
	Underwritten Offering	  	1.1
	Warburg	  	Recitals
	Warrant	  	1.1

  

 iii 

 REGISTRATION RIGHTS AGREEMENT 

REGISTRATION RIGHTS AGREEMENT, dated as of April 7, 2010, by and among Primerica, Inc., a Delaware corporation (the
“Company” or “Primerica”), Warburg Pincus Private Equity X, L.P., a Delaware limited partnership, Warburg Pincus X Partners, L.P. , a Delaware limited partnership (together with Warburg Pincus Private
Equity X L.P., “Warburg”), and Citigroup Insurance Holding Corporation, a Georgia corporation (“Citi”). 

WHEREAS, Primerica, Warburg and Citi have entered into the Securities Purchase Agreement, dated as of February 8, 2010, (as amended,
supplemented, restated or otherwise modified from time to time, the “Purchase Agreement”), pursuant to which, among other things, Citi has agreed to sell to Warburg, and Warburg has agreed to purchase from Citi, shares of
common stock, par value $0.01 per share, of the Company (the “Common Stock”) and warrants to acquire Common Stock and/or non-voting common stock of the Company, par value $0.01 per share (the “Non-Voting
Stock”). 
 WHEREAS, in connection with the execution of the Purchase Agreement, Primerica has agreed to provide to
Warburg and Citi certain rights as set forth herein. 
 NOW, THEREFORE, in consideration of the premises and of the mutual
covenants and obligations hereinafter set forth, the parties hereto hereby agree as follows: 
 ARTICLE I 

DEFINITIONS 

Section 1.1. Certain Defined Terms. As used herein, the following terms shall have the following meanings (capitalized terms not
defined herein shall the meanings assigned to them in the Purchase Agreement): 
 “Action” means any
legal, administrative, regulatory or other suit, action, claim, audit, assessment, arbitration or other proceeding, investigation or inquiry. 

“Affiliate” means, with respect to any person, any person directly or indirectly controlling, controlled by or
under common control with, such other person. For purposes of this definition, “control” (including, with correlative meaning, the terms “controlled by” and “under common control
with”) when used with respect to any person, means the possession, directly or indirectly, of the power to cause the direction of management or policies of such person, whether through the ownership of voting securities, by contract or
otherwise. 
 “Agreement” means this Registration Rights Agreement, as it may be amended, supplemented,
restated or modified from time to time. 
 “Beneficial Ownership” by a Person of any securities includes
ownership by any Person who, directly or indirectly, through any contract, arrangement, understanding, relationship or otherwise, has or shares (i) voting power which includes the power to vote, or to direct the voting of, such security; and/or
(ii) investment power which includes the power to dispose, or to direct 
  

 1 

 
the disposition, of such security; and shall otherwise be interpreted in accordance with the term “beneficial ownership” as defined in Rule 13d-3 adopted by the SEC under the Exchange
Act. The term “Beneficially Own” shall have a correlative meaning. 
 “Business
Day” means any day except Saturday, Sunday and any day which shall be a legal holiday or a day on which banking institutions in the State of New York generally are authorized or required by law or other governmental actions to close.

 “Citi Affiliated Group” means Citi and its Affiliates (excluding Primerica). 

“Citi Note” means that certain note issued by Primerica to Citi on April 1, 2010 in the amount of $300
million, and any note subsequently issued by Primerica to any member of the Citi Affiliated Group in exchange therefor. 

“Company Subsidiaries” has the meaning assigned to such term in the Purchase Agreement. 

“Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated
by the SEC from time to time thereunder. 
 “Full Cooperation” means, in connection with any Fully
Marketed Underwritten Offering, in addition to the other cooperation otherwise required by this Agreement, (a) members of senior management of Primerica (including the co-chief executive officers and the chief financial officer) shall fully
cooperate with the underwriter(s) in connection therewith, and make themselves available to participate in all of the marketing processes of the Fully Marketed Underwritten Offering as recommended by the underwriter(s), and (b) Primerica shall
prepare preliminary and final Prospectuses for use in connection with such offering containing such additional information as reasonably requested by the underwriter(s) (in addition to the minimum information required by law, rule or regulation).

 “Fully Marketed Underwritten Offering” means an Underwritten Offering which includes due diligence
sessions, road shows, one-on-one meetings with prospective purchasers of the Registrable Securities, and other customary marketing activities, as recommended by the underwriter(s). 

“Governmental Entity” means any governmental or regulatory federal, state, local and foreign authority, agency,
court, commission or other entity, including any stock exchange or other self-regulatory organization. 

“Holders” means Warburg, Citi and any permitted transferee of Registrable Securities. 

“Independent Contractor Representatives” means all individuals who render services to Primerica or any of its
subsidiaries who are classified by Primerica or such subsidiary as having the status of an independent contractor. 

“Initial Public Offering” means Primerica’s firm commitment underwritten initial public offering filed under
the Securities Act covering the offer and sale of Common Stock. 
  

 2 

 “Intercompany Agreement” means that certain intercompany agreement,
dated as of April 7, 2010, entered into between Primerica and Citigroup Inc., a Delaware corporation. 
 “IPO
S-1” means Primerica’s registration statement on Form S-1 (No. 333-162918), as amended and filed with the SEC. 

“Issuer Free Writing Prospectus” means an issuer free writing prospectus, as defined in Rule 433 under the
Securities Act, relating to an offer of the Registrable Securities. 
 “Law” means legislation, code,
ordinance, writ, statute, treaty, rule, order, directive, bulletin, decree or regulation (including common law) of any Governmental Entities, including any publicly available binding judicial or administrative interpretation thereof. 

“Person” has the meaning given to it in Section 3(a)(9) of the Exchange Act and as used in Sections 13(d)(3)
and 14(d)(2) of the Exchange Act. 
 “Privilege” means the attorney-client privilege, the work product
doctrine, or any other applicable protective privilege. 
 “Prospectus” means the prospectus included in
any Registration Statement (including a prospectus that discloses information previously omitted from a prospectus filed as part of an effective Registration Statement in reliance upon Rule 430A promulgated under the Securities Act), as amended or
supplemented by any prospectus supplement with respect to the terms of the offering of any portion of the Registrable Securities covered by such Registration Statement, any Issuer Free Writing Prospectus related thereto, and all other amendments and
supplements to such prospectus, including post-effective amendments, and all material incorporated by reference or deemed to be incorporated by reference in such prospectus. 

“Registrable Securities” means all shares of Common Stock held by a Holder and any securities issued directly or
indirectly with respect to such shares because of stock splits, stock dividends, reclassifications, recapitalizations, mergers, consolidations, or similar events, including any shares of Common Stock held by Warburg as a result of the exercise of
the Warrant or Additional Warrant or as a result of a conversion or exchange of Non-Voting Stock provided, that any shares of Common Stock held by Warburg that shall be subject to the restrictions on transfer set forth in Section 4.2 of
the Purchase Agreement, shall not be Registrable Securities until such time as such restrictions on transfer shall expire or otherwise terminate or be waived in accordance with the terms of Section 4.2 of the Purchase Agreement. As to any
particular Registrable Securities, such securities shall cease to be Registrable Securities when (i) a Registration Statement with respect to the sale of such securities shall have become effective under the Securities Act and such securities
shall have been sold or disposed of in accordance with such Registration Statement, (ii) such securities shall have been sold or disposed of pursuant to Rule 144 (or any successor provision) under the Securities Act or (iii) such
securities may be sold pursuant to Rule 144 (or any successor provision) under the Securities Act without being subject to the volume limitations in subsection (e) of such rule. 

“Registration Statement” means any registration statement of Primerica under the Securities Act that permits the
public offering of any of the Registrable Securities pursuant to the provisions of this Agreement, including the Prospectus, amendments and supplements to such 

 

 3 

 
registration statement, including post-effective amendments, all exhibits and all material incorporated by reference or deemed to be incorporated by reference in such registration statement.

 “Rule 144” means Rule 144 under the Securities Act, as such rule may be amended from time to time, or
any successor rule that may be promulgated by the SEC. 
 “Rule 144A” means Rule 144A under the
Securities Act, as such rule may be amended from time to time, or any successor rule that may be promulgated by the SEC. 

“SEC” means the United States Securities and Exchange Commission. 

“Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated by the
SEC from time to time thereunder. 
 “Selling Holder” means each Holder of Registrable Securities
participating in a registration pursuant to Article II. 
 “Subsidiary” means those corporations, banks,
savings banks, associations and other persons of which such person owns or controls 51% or more of the outstanding equity securities either directly or through an unbroken chain of entities as to each of which 51% or more of the outstanding equity
securities is owned directly or indirectly by its parent; provided, however, that there shall not be included any such entity to the extent that the equity securities of such entity were acquired in satisfaction of a debt previously
contracted in good faith or are owned or controlled in a bona fide fiduciary capacity. 
 “Underwritten
Offering” means a registration in which Common Stock of Primerica is sold to an underwriter for reoffering to the public. 

Section 1.2. Terms Generally. The definitions in Section 1.1 shall apply equally to both the singular and plural forms of the
terms defined. Whenever the context may require, any pronoun shall include the corresponding masculine, feminine and neuter forms. The words “include”, “includes” and “including” shall be deemed to be followed by the
phrase “without limitation”, unless the context expressly provides otherwise. All references herein to Sections, paragraphs, subparagraphs, clauses, Exhibits or Schedules shall be deemed references to Sections, paragraphs, subparagraphs or
clauses of, or Exhibits or Schedules to this Agreement, unless the context requires otherwise. Unless otherwise expressly defined, terms defined in this Agreement have the same meanings when used in any Exhibit or Schedule hereto. Unless otherwise
specified, the words “this Agreement”, “herein”, “hereof”, “hereto” and “hereunder” and other words of similar import refer to this Agreement as a whole (including the Schedules and Exhibits) and not
to any particular provision of this Agreement. The term “or” is not exclusive. The word “extent” in the phrase “to the extent” shall mean the degree to which a subject or other thing extends, and such phrase shall not
mean simply “if”. Unless expressly stated otherwise, any Law defined or referred to herein means such Law as from time to time amended, modified or supplemented, including by succession of comparable successor Laws and references to all
attachments thereto and instruments incorporated therein. References to a Person are also to its permitted successors and assigns. The table of contents and headings contained in this Agreement are for reference purposes only and shall not affect in
any way the meaning or interpretation of this Agreement. 
  

 4 

 ARTICLE II 

REGISTRATION RIGHTS 

Section 2.1. Piggyback Registrations. 

(a) Right to Piggyback. Whenever Primerica proposes to register for sale under the Securities Act or publicly sell
under a “shelf” registration statement any Common Stock (or securities convertible into or exchangeable or exercisable for Common Stock) for its own account or the account of any stockholder of Primerica (other than the Initial Public
Offering of Common Stock contemplated by the IPO S-1, offerings pursuant to employee benefit plans, or noncash offerings in connection with a proposed acquisition, exchange offer, recapitalization or similar transaction) and the registration form to
be used may be used for the registration of Registrable Securities (a “Piggyback Registration”), Primerica will give prompt written notice to the Holders and to all other holders of Common Stock having similar registration
rights of its intention to effect such a registration or sale and, subject to Section 2.1(b) hereof, shall include in such transaction all Registrable Securities with respect to which Primerica has received written request for inclusion
therein within 15 days after receipt of Primerica’s notice. 
 (b) Priority. If a registration or
sale pursuant to this Section 2.1 involves an Underwritten Offering and the managing underwriter advises Primerica in good faith that in its opinion the number of securities requested to be included in such registration or sale exceeds
the number which can be sold in such offering without having an adverse effect on such offering, including the price at which such securities can be sold, then Primerica will be required to include in such registration the maximum number of shares
that such underwriter advises can be so sold, allocated: 
 (i) if such offering was initiated by Primerica as a
primary offering on behalf of Primerica, (x) first, to the securities Primerica proposes to sell, (y) second, among the shares of Common Stock requested to be included in such offering by any of the Holders, pro rata, on the
basis of the aggregate number of shares of Common Stock and Non-Voting Stock owned by any such requesting Holder and its Affiliates vis-a-vis the other requesting Holders and their Affiliates on the date of such request, and (z) third, among
other securities, if any, requested and otherwise eligible to be included in such offering; 
 (ii) if such
offering was initiated by a security holder of Primerica (other than any Holder) as a secondary offering on behalf of such security holder (w) first, among the shares of Common Stock requested to be included in such offering by each Holder,
pro rata, on the basis of the aggregate number of shares of Common Stock and Non-Voting Stock owned by any such requesting Holder and its Affiliates vis-a-vis the other requesting Holders and their Affiliates on the date of such
request, (x) second, among the shares of Common Stock requested to be included in such offering by such requesting security holder, (y) third, among the shares of Common Stock requested to be included in

  

 5 

 
such offering by any other stockholder of Primerica owning shares of Common Stock eligible for registration, and (z) fourth, among other securities, if any, requested and otherwise eligible
to be included in such offering (including securities to be sold for the account of Primerica). 
 (iii) if such
offering was initiated by any Holder as a secondary offering on behalf of such Holder, (x) first, to shares of Common Stock requested to be included in such offering by each Holder, pro rata, on the basis of the aggregate number of
shares of Common Stock and Non-Voting Stock owned by any such requesting Holder and its Affiliates vis-a-vis the other requesting Holders and their Affiliates on the date of such request, (y) second, among the shares of Common Stock requested
to be included in such offering by any other stockholder of Primerica owning shares of Common Stock eligible for registration, and (z) third, among other securities, if any, requested and otherwise eligible to be included in such offering
(including securities to be sold for the account of Primerica). 
 (c) Withdrawal of Registrations. In the
case of an offering initiated by Primerica as a primary offering on behalf of Primerica, nothing contained herein shall prohibit Primerica from determining, at any time, not to file a registration statement or, if filed, to withdraw such
registration or terminate or abandon the offering related thereto, without prejudice, however, to the rights of the Holders to immediately request a registration pursuant to Section 2.2 hereof. 

Section 2.2. Requested Registrations. 

(a) Right to Request Shelf Registration. At any time after the date hereof when Primerica is eligible to register
shares of Common Stock on Form S-3 (or a successor form), upon the written request of any Holder, Primerica shall use commercially reasonable efforts to promptly file a registration statement (which, if permitted, shall be an “automatic shelf
registration statement” as defined in Rule 405 under the Securities Act) on Form S-3 or such other form under the Securities Act then available to Primerica providing for the resale pursuant to Rule 415 from time to time of all or part of the
Registrable Securities (including the Prospectus, amendments and supplements to the shelf registration statement or Prospectus, including pre- and post-effective amendments, all exhibits thereto and all material incorporated by reference or deemed
to be incorporated by reference, if any, in such shelf registration statement, the “Shelf Registration Statement”). If Primerica files any shelf registration statement for its own benefit or for the benefit of the holders of
any of its securities other than the Holders, Primerica agrees that it shall use its reasonable best efforts to include in such registration statement such disclosures as may be required by Rule 430B under the Securities Act in order to ensure that
the Holders may be added to such shelf registration statement at a later time through the filing of a Prospectus supplement rather than a post-effective amendment. Primerica shall use commercially reasonable efforts to cause the Shelf Registration
Statement to be declared effective by the SEC as promptly as practicable following such filing. Primerica shall maintain the effectiveness of the Shelf Registration Statement for the maximum period permitted by SEC rules. The plan of

  

 6 

 
distribution contained in the Shelf Registration Statement (or related Prospectus supplement) shall be determined by Citi, if any member of the Citi Affiliated Group is a requesting Holder for
such Shelf Registration Statement, or otherwise by the other requesting Holder or Holders. Each Holder shall be entitled to an unlimited number of Fully Marketed Underwritten Offerings pursuant to the Shelf Registration Statement so long as the
Registrable Securities proposed to be sold in each such offering either (1) equals or exceeds five percent (5%) of the number of shares of Common Stock outstanding at the time of the written request or (2) represents all of the
remaining Registrable Securities owned by the requesting Holder and its Affiliates. If a Fully Marketed Underwritten Offering is requested, Primerica shall cause there to occur Full Cooperation in connection therewith. Except as provided in this
Section 2.2(a) with respect to Underwritten Offerings, there shall be no limitation on the number of takedowns off the Shelf Registration Statement. 

(b) Right to Request Additional Demand Registrations. At any time after the date hereof, upon the written request
of any Holder requesting that Primerica effect the registration under the Securities Act of all or part of the Registrable Securities pursuant to a registration statement separate from a Shelf Registration Statement (a “Demand
Registration”) (other than the Initial Public Offering of Primerica’s Common Stock contemplated by the IPO S-1), Primerica shall use commercially reasonable efforts to effect, as expeditiously as possible, the registration under
the Securities Act of such number of Registrable Securities requested to be so registered; provided, that Primerica shall not be required to file a registration statement pursuant to this Section 2.2(b) unless the number of Registrable
Securities proposed to be included therein either (1) equals or exceeds five percent (5%) of the number of shares of Common Stock outstanding as of the time of such request or (2) represents all of the remaining Registrable Securities
owned by the requesting Holder. In connection with each such Demand Registration, Primerica shall cause there to occur Full Cooperation. Promptly after receipt of any such request for Demand Registration, Primerica shall give written notice of such
request to each other Holder and to all other holders of Common Stock having rights to have their shares included in such registration and shall, subject to the provisions of Section 2.2(c) hereof, include in such registration all such
Registrable Securities with respect to which all stockholders having such rights have requested to be so registered. 

(c) Priority. If a requested registration pursuant to this Section 2.2 involves an Underwritten
Offering and the managing underwriter shall advise Primerica in good faith that in its opinion the number of securities requested to be included in such registration exceeds the number which can be sold in such offering without having an adverse
effect on such offering, including the price at which such securities can be sold, then Primerica will be required to include in such registration the maximum number of shares that such underwriter advises can be so sold, allocated (except in
situations where the last sentence of this Section 2.2(c) applies): 
 (i) first, to Registrable
Securities requested by all Holders (including any Holders that did not exercise their Demand Registration rights pursuant to Section 2.2(b)) to be included in such registration, pro rata on the basis of the aggregate number of
shares of Common Stock and Non-Voting Stock owned by any such requesting Holder and its Affiliates vis-a-vis the other requesting Holders and their Affiliates on the date of such request; and Affiliates vis-a-vis the other requesting Holders and
their Affiliates on the date of such request; and 
  

 7 

 (ii) second, among all shares of Common Stock requested to be included in
such registration by any other stockholder of Primerica owning shares of Common Stock eligible for such registration; and 

(iii) third, among other securities, if any, requested and otherwise eligible to be included in such registration
(including securities to be sold for the account of Primerica). 
 If the Board of Directors of Primerica determines in its good faith judgment
that Primerica needs to raise common equity capital in the public capital markets to either (x) make a capital contribution to one of its principal insurance company Subsidiaries as requested by the principal regulator for such insurance
company Subsidiary or to maintain the financial strength rating of such insurance company Subsidiary, (y) deleverage Primerica to address potential financial covenant defaults under any material debt agreement, or (z) use the proceeds
thereof to repay the Citi Note, then Primerica shall have the right to include in such offering up to fifty percent (50%) of the total number of shares of securities that such underwriter advises can be so sold in such offering. 

A registration will be deemed to be initiated by Primerica if Primerica provides written notice to the Holders of its intention to effect such a
registration or sale pursuant thereto. 
 (d) Preemption of Demand Registration. Notwithstanding the
foregoing, if the Board of Directors of Primerica determines in its good faith judgment, (i) that the disclosures that would be required to be made by Primerica in connection with such registration would be materially harmful to Primerica
because of transactions then being considered by, or other events then concerning, Primerica, or would otherwise have a material adverse effect on Primerica, then Primerica may defer the filing (but not the preparation) of the registration statement
which is required to effect any registration pursuant to this Section 2.2 for a reasonable period of time, or (ii) that registration at the time would require the inclusion of pro forma or other information, which requirement
Primerica is reasonably unable to comply with, then Primerica may defer the filing (but not the preparation) of the registration statement which is required to effect any registration pursuant to this Section 2.2 for a reasonable period
of time, but not in excess of 45 calendar days (or any longer period agreed to by the requesting holders of Registrable Securities); provided, that at all times Primerica is in good faith using commercially reasonable efforts to file the
registration statement as soon as practicable. Primerica shall provide prompt written notice to the Selling Holders of (x) any deferment of the filing of a Demand Registration pursuant to this Section 2.2(d) and
(y) Primerica’s decision to file such Demand Registration following such deferment. Primerica may defer the filing of a particular Demand Registration pursuant to this Section 2.2(d) only twice during any 12-month period.
Notwithstanding the other provisions of this Section 2.2(d), Primerica may not defer the filing of a Demand Registration past the date that is the earliest of (a) the date that is five Business Days after the date upon which any
disclosure of a matter the Board of Directors of Primerica has determined would be materially harmful to Primerica because of transactions then being considered by, or other events then concerning, Primerica, is disclosed to the public or ceases to
be material, provided, that if filing such 
  

 8 

 
Demand Registration at such time would require the inclusion of financial statements, pro forma or other information, which requirement Primerica is reasonably unable to comply with, then
Primerica may defer such filing for a reasonable period of time, but not in excess of 30 calendar days (or any longer period agreed to by the requesting Holders) so long as at all times Primerica is in good faith using commercially reasonable
efforts to file such Demand Registration as soon as practicable; or (b) such date that, if such deferment continued, would result in there being more than 90 days in the aggregate in any 12 month period during which the filing of one or more
Registration Statements has been so deferred. The period during which a filing is so deferred hereunder is referred to as a “Delay Period.” 

Section 2.3. Holdback Agreements. To the extent requested in writing by the managing underwriter of any Underwritten Offering,
Primerica agrees not to, and shall exercise commercially reasonable efforts to obtain agreements (in the underwriters’ customary form) from its directors, executive officers and Beneficial Owners of five percent (5%) or more of the Common
Stock not to, directly or indirectly offer, sell, pledge, contract to sell (including any short sale), grant any option to purchase or otherwise dispose of any equity securities of Primerica or enter into any hedging transaction relating to any
equity securities of Primerica during the 90 days beginning on the effective date of any underwritten Demand Registration or any underwritten Piggyback Registration or the pricing date of any Underwritten Offering pursuant to any Registration
Statement (except as part of such Underwritten Offering or pursuant to registrations on Form S-8 or S-4 or any successor forms thereto) unless the underwriter managing the offering otherwise agrees to a shorter period. 

Section 2.4. Registration Procedures. In connection with the registration and sale of Registrable Securities pursuant to this
Agreement, Primerica shall use commercially reasonable efforts to effect or cause the registration and the sale of such Registrable Securities in accordance with the intended methods of disposition thereof, and Primerica shall: 

(a) prepare and file with the SEC as expeditiously as possible but in no event later than 90 days after receipt of a
request for registration with respect to such Registrable Securities, a registration statement on any form for which Primerica then qualifies or which counsel for Primerica shall deem appropriate, which form shall be available for the sale of the
Registrable Securities in accordance with the intended methods of distribution thereof and which otherwise complies with the terms of this Agreement, and use commercially reasonable efforts to cause such registration statement to become effective as
soon as practicable; provided, that before filing with the SEC a registration statement or prospectus or any amendments or supplements thereto, including any documents incorporated by reference therein, Primerica shall (x) furnish to the
Selling Holders and to one counsel selected by each of Warburg and its Affiliates (if Selling Holders) on the one hand and the Citi Affiliated Group (if Selling Holders) on the other hand (or by such Holders and holders of all other securities
covered by such registration statement, but in no event to more than two firms of attorneys for all such selling security holders) copies of all such documents proposed to be filed, which documents shall be subject to the review of the Selling
Holders and such counsel, and (y) notify the Selling Holders of any stop order issued or threatened by the SEC and take all reasonable actions required to prevent the entry of such stop order or to remove it if entered. 

 

 9 

 (b) prepare and file with the SEC such amendments and supplements to such
registration statement and the prospectus used in connection therewith as may be necessary to keep such registration statement effective for a period of not less than 180 days in the case of a Demand Registration or the maximum period of time
permitted by SEC rule in the case of a Shelf Registration Statement, or, in either case, such shorter period which shall terminate when all Registrable Securities covered by such registration statement have been sold (but not before the expiration
of the applicable period referred to in Section 4(3) of the Securities Act and Rule 174, or any successor thereto, thereunder, if applicable), and comply with the provisions of the Securities Act with respect to the disposition of all
securities covered by such registration statement during such period in accordance with the intended methods of disposition by the sellers thereof set forth in such registration statement. 

(c) furnish, without charge, to each Selling Holder and each underwriter, if any, such number of copies of such
registration statement, each amendment and supplement thereto (including one conformed copy to each Selling Holder and one signed copy to each managing underwriter and in each case including all exhibits thereto), and the prospectus included in such
registration statement (including each preliminary prospectus), in conformity with the requirements of the Securities Act, and such other documents as the Selling Holders may reasonably request in order to facilitate the disposition of the
Registrable Securities registered thereunder. 
 (d) use commercially reasonable efforts to register or qualify
such Registrable Securities covered by such registration statement under such other securities or blue sky laws of such jurisdictions as the Selling Holders, and the managing underwriter, if any, reasonably requests and do any and all other acts and
things which may be reasonably necessary or advisable to enable the Selling Holders and each underwriter, if any, to consummate the disposition in such jurisdictions of the Registrable Securities registered thereunder; provided, that
Primerica shall not be required to (i) qualify generally to do business in any jurisdiction where it would not otherwise be required to qualify but for this paragraph (d), (ii) subject itself to taxation in any such jurisdiction or
(iii) consent to general service of process in any such jurisdiction. 
 (e) use commercially reasonable
efforts to cause the Registrable Securities covered by such registration statement to be registered with or approved by such insurance regulatory authorities as may be necessary by virtue of the business and operations of Primerica to enable the
Selling Holders to consummate the disposition of Registrable Securities registered thereunder. 
 (f) immediately
notify the managing underwriter, if any, and the Selling Holders at any time when a prospectus relating thereto is required to be delivered under the Securities Act, of the happening of any event which comes to Primerica’s attention if as a
result of such event the prospectus included in such registration statement contains an untrue statement of a material fact or omits to state any material fact required to be stated therein or necessary to make the statements therein not misleading
(a “Suspension Notice”), and Primerica shall promptly prepare and furnish to the Selling Holders a supplement or amendment to such prospectus so that as thereafter delivered, such prospectus shall not contain an untrue
statement of a material fact or omit to state any material fact required to be stated therein or 
  

 10 

 
necessary to make the statements therein not misleading; provided, however, that if the Board of Directors of Primerica determines in its good faith judgment, (i) that the disclosure that
would be required to be made by Primerica would be materially harmful to Primerica because of transactions then being considered by, or other events then concerning, Primerica, or would otherwise have a material adverse effect on Primerica, then
Primerica may defer the furnishing to the Selling Holders a supplement or amendment to such prospectus for a reasonable period of time, or (ii) a supplement or amendment to such prospectus at such time would require the inclusion of pro forma
or other information, which requirement Primerica is reasonably unable to comply with, then Primerica may defer the furnishing to the Selling Holders a supplement or amendment to such prospectus for a reasonable period of time, but not in excess of
45 calendar days (or any longer period agreed to by the requesting holders of Registrable Securities); provided, that at all times Primerica is in good faith using commercially reasonable efforts to file such amendment or supplement as soon as
practicable; provided, however, that such deferrals shall not exceed 90 days in the aggregate in any 12 month period. In any event, Primerica shall not be entitled to deliver more than a total of three (3) Suspension Notices or notices of any
Delay Period in any 12 month period. 
 (g) promptly notify the managing underwriter, if any, and the Selling
Holders: 
 (i) when the Registration Statement, any pre-effective amendment, the Prospectus or any Prospectus
supplement or post-effective amendment to the Registration Statement has been filed and, with respect to the Registration Statement or any post-effective amendment, when the same has become effective; 

(ii) of any written request by the SEC for amendments or supplements to the Registration Statement or any Prospectus or
of any inquiry by the SEC relating to the Registration Statement or Primerica’s status as a well-known seasoned issuer; 

(iii) of the receipt by Primerica of any notification with respect to the suspension of the qualification of any
Registrable Securities for sale under the applicable securities or blue sky laws of any jurisdiction; 
 (h) in
the case of an Underwritten Offering, (i) enter into such agreements (including underwriting agreements in customary form), (ii) take all such other actions as the Selling Holders or the underwriter(s) reasonably request in order to
expedite or facilitate the disposition of such Registrable Securities (including causing senior management and Primerica personnel to cooperate with the Selling Holders and the underwriter(s) in connection with performing due diligence) and
(iii) cause its counsel to issue opinions of counsel in form, substance and scope as are customary in primary underwritten offerings, addressed and delivered to the underwriter(s) and the Selling Holders; 

(i) use commercially reasonable efforts to cause all such securities being registered to be listed on each securities
exchange on which similar securities issued by Primerica are then listed, and enter into such customary agreements including a listing application and indemnification agreement in customary form, provided that the applicable listing
requirements are satisfied, and to provide a transfer agent and registrar for such Registrable Securities covered by such registration statement no later than the effective date of such registration statement; 

 

 11 

 (j) make available for inspection by the Holders and any holder of
securities covered by such registration statement, any underwriter participating in any distribution pursuant to such registration statement, and any attorney, accountant or other agent retained by such persons (collectively, the
“Inspectors”), all financial and other records, pertinent corporate documents and properties of Primerica and its Subsidiaries (collectively, “Primerica Records”), if any, as shall be reasonably
necessary to enable them to exercise their due diligence responsibilities, and cause Primerica’s and its Subsidiaries’ officers, directors, employees and Independent Contractor Representatives to supply all information and respond to all
inquiries reasonably requested by any such Inspector in connection with such registration statement. Notwithstanding the foregoing, Primerica shall have no obligation to disclose any Primerica Records to the Inspectors in the event Primerica
determines that such disclosure is reasonably likely to have an adverse effect on Primerica’s ability to assert the existence of a Privilege with respect thereto; 

(k) if requested, use commercially reasonable efforts to obtain a “cold comfort” letter from Primerica’s
independent public accountants in customary form and covering such matters of the type customarily covered by “cold comfort” letters; 

(l) in connection with each Demand Registration and each Fully Marketed Underwritten Offering, cause there to occur Full
Cooperation and, in all other cases, make available senior management personnel to participate in, and cause them to cooperate with the underwriters in connection with, “road show” and other customary marketing activities, including
“one-on-one” meetings with prospective purchasers of the Registrable Securities; 
 (m) otherwise use
commercially reasonable efforts to comply with all applicable rules and regulations of the SEC, and make available to its security holders, as soon as reasonably practicable, an earning statement covering a period of at least 12 months, beginning
with the first month after the effective date of the registration statement (as the term “effective date” is defined in Rule 158(c) under the Securities Act), which earning statement shall satisfy the provisions of Section 11(a) of
the Securities Act and Rule 158 thereunder; and 
 (n) if requested to do so by the Selling Holders, use
commercially reasonable efforts to create a depositary arrangement whereby depositary shares representing fractional shares of Registrable Securities will be issued and to cause to be prepared and to execute customary documentation with respect to
such depositary arrangement and such other documentation that the Selling Holders may reasonably request in order to facilitate the disposition of the depositary shares created thereunder (including engaging a depositary and preparing and executing
a depositary agreement). 
 It shall be a condition precedent to the obligation of Primerica to take any action pursuant to
this Agreement in respect of the Registrable Securities which are to be registered at the request of any Holder that such Holder shall furnish to Primerica such information regarding the securities held by such Holder and the intended method of
disposition thereof as Primerica shall reasonably request and as shall be required in connection with the action to be taken by Primerica. 
  

 12 

 Section 2.5. Restriction on Disposition of Registrable Securities. Citi and Warburg
agree that, upon receipt of a Suspension Notice, Citi and Warburg shall, and Warburg shall cause each of its Affiliates to, and Citi shall cause each member of the Citi Affiliated Group to, discontinue disposition of Registrable Securities pursuant
to the registration statement covering such Registrable Securities until receipt of the copies of the supplemented or amended prospectus contemplated by Section 2.4(f) hereof, or until otherwise notified by Primerica, and, if so directed
by Primerica, Citi and Warburg shall, and Warburg shall cause each of its Affiliates to, and Citi shall cause each member of the Citi Affiliated Group to, deliver to Primerica (at Primerica’s expense) all copies (including any and all drafts),
other than permanent file copies, then in their possession, of the prospectus covering such Registrable Securities at the time of receipt of such notice. In the event Primerica shall give any Suspension Notice, the 180-day period mentioned in
Section 2.4(b) hereof shall be extended by the greater of (x) three months or (y) the number of days during the period from and including the date of the Suspension Notice to and including the date when the Selling Holders
shall have received the copies of the supplemented or amended prospectus contemplated by Section 2.4(f) hereof. 

Section 2.6. Selection of Underwriters. 

(a) For an Underwritten Offering made pursuant to a registration requested by any member of the Citi Affiliated Group
pursuant to Section 2.2(b) hereof, Citi shall have the right to select a managing underwriter or underwriters to administer the offering, which may be Citigroup Global Markets Inc. 

(b) For an Underwritten Offering made pursuant to a registration requested by Warburg or any of its Affiliates pursuant to
Section 2.2(b) hereof, Warburg shall have the right to select a managing underwriter or underwriters to administer the offering. 

(c) For an Underwritten Offering in which both a member of the Citi Affiliated Group, on the one hand, and any of Warburg
or its Affiliates, on the other hand, are participating with estimated aggregate gross proceeds to each of the Citi Affiliated Group, on the one hand, and Warburg and its Affiliates, on the other hand, of at least $10 million, each of Citi and
Warburg shall be permitted to select a co-lead managing underwriter and a co-book runner to administer such Underwritten Offering. 

Section 2.7. Registration Expenses. Primerica shall pay for all costs and expenses with respect to its compliance with its
obligations in connection with a registration pursuant to this Agreement, including: (i) all registration and filing fees, (ii) fees and expenses of compliance with securities or blue sky laws (including reasonable fees and disbursements
of counsel in connection with blue sky qualifications of the Registrable Securities), (iii) printing expenses, (iv) internal expenses (including all salaries and expenses of its officers and employees performing legal or accounting
duties), (v) the fees and expenses incurred in connection with the listing of the Registrable Securities on any national securities exchange or interdealer quotation system, (vi) the reasonable fees and disbursements of counsel for
Primerica and customary fees and expenses for independent certified public accountants retained by Primerica (including the 
  

 13 

 
expenses of any comfort letters or costs associated with the delivery by independent certified public accountants of a comfort letter or comfort letters), (vii) the reasonable fees and
disbursements of not more than two firms of attorneys acting as legal counsel for all of the selling stockholders, collectively, (viii) the fees and expenses of any registrar and transfer agent or any depositary, (ix) the underwriting
fees, discounts and commissions applicable to any Common Stock sold for the account of Primerica and (x) the cost of preparing all documentation in connection therewith. Except as otherwise provided in clause (ix) of this
Section 2.7, Primerica shall have no obligation to pay any underwriting fees, discounts, commissions or expenses attributable to the sale of Registrable Securities, including the fees and expenses of any underwriters and such
underwriters’ counsel or the costs and expenses of any insurance regulatory filings resulting from such sale. 
 Section
2.8. Conversion of Other Securities. If any holder of Registrable Securities offers any options, rights, warrants or other securities issued by it or any other person that are offered with, convertible into or exercisable or exchangeable for
any Registrable Securities, the Registrable Securities underlying such options, rights, warrants or other securities shall be eligible for registration pursuant to Sections 2.1 and 2.2 hereof. 

Section 2.9. Rule 144; Rule 144A. If and for so long as Primerica is subject to the reporting requirements of the Exchange Act,
Primerica shall take such measures and file such information, documents and reports as shall be required by the SEC as a condition to the availability of Rule 144 or Rule 144A (or any successor provisions) under the Securities Act. 

Section 2.10. Transfer of Registration Rights. 

(a) Any member of the Citi Affiliated Group and, subject to Section 4.2 of the Purchase Agreement, any of Warburg or
any of its Affiliates may transfer all or any portion of its rights under this Agreement to any transferee of Registrable Securities constituting not less than 5% of the outstanding shares of Common Stock (each, a “transferee”) of
Registrable Securities; provided, however, that no such minimum share assignment requirement shall be necessary for an assignment by a Holder which is (A) a partnership to its partners in accordance with partnership interests,
(B) a limited liability company to its members in accordance with their interest in the limited liability company, or (C) a corporation to its stockholders in accordance with their interests in the corporation. Any transfer of registration
rights pursuant to this Section 2.10 shall be effective upon receipt by Primerica of written notice from such Holder stating the name and address of any transferee and identifying the amount of Registrable Securities with respect to
which the rights under this Agreement are being transferred and the nature of the rights so transferred. In connection with any such transfer, the term “Holder,” “Warburg,” “Citi” or “member of the Citi Affiliated
Group” as used in this Agreement shall, where appropriate to assign such rights and obligations to such transferee, be deemed to refer to or include the transferee holder of such Registrable Securities. Any member of the Citi Affiliated Group,
and Warburg and its Affiliates, may exercise their rights hereunder in such proportion as they shall agree among themselves. 

(b) After such transfer, each Holder shall retain its rights under this Agreement with respect to all other Registrable
Securities owned by such Holder. 
  

 14 

 (c) Upon the request of any Holder, Primerica shall execute a Registration
Rights Agreement with such transferee or a proposed transferee substantially similar to this Agreement. 
 Section 2.11. Free
Writing Prospectuses. Primerica shall not permit any officer, director, underwriter, broker or other Person acting on behalf of Primerica to use any free writing prospectus (as defined in Rule 405 under the Securities Act) in connection with any
registration statement covering Registrable Securities without the prior written consent of the Selling Holders and any underwriter. 

Section 2.12. Certain Additional Agreements. If any Registration Statement or comparable statement under state “blue
sky” laws refers to any Holder by name or otherwise as the Holder of any securities of Primerica, then such Holder shall have the right to require (a) the insertion therein of language, in form and substance satisfactory to such Holder and
Primerica, to the effect that the holding by such Holder of such securities is not to be construed as a recommendation by such Holder of the investment quality of Primerica’s securities covered thereby and that such holding does not imply that
such Holder will assist in meeting any future financial requirements of Primerica, or (b) in the event that such reference to such Holder by name or otherwise is not in the judgment of Primerica, as advised by counsel, required by the
Securities Act or any similar federal statute or any state “blue sky” or securities law then in force, the deletion of the reference to such Holder; provided, however, that if any Registration Statement refers to any Holder
by name or otherwise as the holder of any securities of Primerica and if in such Holder’s sole and exclusive judgment, such Holder is or might be deemed to be an underwriter or a controlling Person of Primerica, such Holder shall have the right
to require (i) the insertion therein of language, in form and substance reasonably satisfactory to such Holder and Primerica and presented to Primerica in writing, to the effect that the holding by such Holder of such securities is not to be
construed as a recommendation by such Holder of the investment quality of Primerica’s securities covered thereby and that such holding does not imply that such Holder will assist in meeting any future financial requirements of Primerica, or
(ii) in the event that such reference to such Holder by name or otherwise is not required by the Securities Act or any similar federal statute or any state “blue sky” or securities law then in force, the deletion of the reference to
such Holder; provided that with respect to this clause (ii), if reasonably requested by Primerica, such Holder shall furnish to Primerica an opinion of counsel to such effect, which opinion of counsel shall be reasonably satisfactory to Primerica.

  

 15 

 Section 2.13. Other Registration Rights. Without the prior written consent of both
Citi and Warburg (provided that (a) the consent of Citi shall not be required in the event that the Citi Affiliated Group shall cease to own Common Stock representing at least five percent of the outstanding Common Stock and (b) the
consent of Warburg shall not be required in the event that Warburg and its Affiliates shall cease to own Common Stock representing at least five percent of the outstanding Common Stock), Primerica shall not grant to any Person the right to have
securities of Primerica owned by them to be registered with the SEC for resale in an Underwritten Offering or otherwise, except such rights as (i) are not more favorable than the rights granted herein to the Holders, (ii) are not
inconsistent with the rights granted to the Holders and (iii) do not adversely affect the priorities set forth herein of the Holders. The foregoing covenant shall not apply to registration on Form S-8 or any successor form thereto for the
registration of securities issuable pursuant to employee benefit plans. 
 Section 2.14. Indemnification. 

(a) Indemnification by the Company. The Company shall indemnify and hold harmless, to the fullest extent permitted
by Law, each Selling Holder whose Registrable Securities are covered by a Registration Statement or Prospectus, the officers, directors, partners (limited and general), members, managers, shareholders, accountants, attorneys, agents and employees of
each of them, each Person who controls (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) each such Selling Holder and the officers, directors, partners (limited and general), members, managers,
shareholders, accountants, attorneys, agents and employees of each such controlling Person, and each underwriter (including any Holder that is deemed to be an underwriter pursuant to any SEC comments or policies), if any, and each Person who
controls (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) such underwriter (collectively, “Holder Indemnitees”), from and against any and all losses, claims, damages,
liabilities, expenses (including, without limitation, costs of preparation and reasonable attorneys’ fees and any other reasonable fees or expenses incurred by such party in connection with any investigation or Action), judgments, fines,
penalties, charges and amounts paid in settlement (collectively, “Losses”), as incurred, arising out of or based upon (i) any untrue statement (or alleged untrue statement) of a material fact contained in any applicable
Registration Statement or any amendment of or supplement to any of the foregoing or other document incident to any such registration, qualification, or compliance, or the omission (or alleged omission) to state therein a material fact required to be
stated therein or necessary to make the statements therein not misleading, (ii) any untrue statement (or alleged untrue statement) of a material fact contained in any preliminary or final Prospectus, any document incorporated by reference
therein or any Issuer Free Writing Prospectus, or the omission or alleged omission to state therein a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which
they were made, not misleading, and (iii) any violation by the Company of any Law applicable in connection with any such registration, qualification, or compliance; provided, that the Company will not be liable to a Selling Holder or
underwriter, as the case may be, in any such case to the extent that any such Loss arises out of or is based on any untrue statement or omission by such Selling Holder or underwriter, as the case may be, but only to the extent, that such untrue
statement (or alleged untrue statement) or omission (or alleged omission) is made in such Registration Statement (or in any preliminary or final Prospectus contained 

 

 16 

 
therein, any document incorporated by reference therein or Issuer Free Writing Prospectus related thereto), or any amendment of or supplement to any of the foregoing or other document in reliance
upon and in conformity with written information furnished to the Company by such Selling Holder specifically for inclusion in such document, which information shall specifically be set forth in a separate letter signed by the Selling Holders that
shall be requested by the Company prior to the effectiveness of any Registration Statement in which a Selling Holder is participating by registering Registrable Securities; and provided, further, that the Company will not be liable to any
Person who participates as an underwriter in any underwritten offering or sale of Registrable Securities, or to any Person who is a Selling Holder in any non-underwritten offering or sale of Registrable Securities, or any other Person, if any, who
controls such underwriter or Selling Holder within the meaning of the Securities Act, under the indemnity agreement in this Section 2.14 with respect to any preliminary Prospectus or the final Prospectus (including any amended or supplemented
preliminary or final Prospectus), as the case may be, to the extent that any such loss, claim, damage or liability of such underwriter, Selling Holder or controlling Person results from the fact that such underwriter or Selling Holder sold
Registrable Securities to a Person to whom there was not sent or given, at or prior to the written confirmation of such sale, a copy of the final Prospectus as then amended or supplemented, whichever is most recent, if the Company has previously
furnished copies thereof to such underwriter or selling Holder and such final Prospectus, as then amended or supplemented, has corrected any such misstatement or omission (such failure to send or deliver, a “Delivery Failure”). Such
indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of any Holder Indemnitee or any other Holder and shall survive the transfer of such securities. The foregoing indemnity agreement is in addition to
any liability that the Company may otherwise have to each Holder Indemnitee. 
 (b) Indemnification by Selling
Holders. In connection with any Registration Statement in which a Selling Holder is participating by registering Registrable Securities, such Selling Holder agrees, severally and not jointly with any other Person, to indemnify and hold harmless,
to the fullest extent permitted by Law, the Company, the officers and directors of the Company, and each Person who controls (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) the Company, and each
underwriter, if any, and each Person who controls (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) such underwriter (collectively, “Company Indemnitees”), from and against
all Losses, as incurred, arising out of or based on (i) any untrue statement (or alleged untrue statement) of a material fact contained in any such Registration Statement (or in any preliminary or final Prospectus contained therein, any
document incorporated by reference therein or Issuer Free Writing Prospectus related thereto) or any amendment of or supplement to any of the foregoing, or any omission (or alleged omission) to state therein a material fact required to be stated
therein or necessary to make the statements therein (in the case of a final or preliminary Prospectus, in light of the circumstances under which they were made) not misleading, in each case solely to the extent that such untrue statement (or alleged
untrue statement) or omission (or alleged omission) is made in such Registration Statement (or in any preliminary or final Prospectus contained therein, any document incorporated by reference therein or Issuer Free Writing Prospectus related
thereto), or any amendment of or supplement to any of the foregoing or other document, in reliance upon and in conformity with written information relating to such 

 

 17 

 
Selling Holder furnished to the Company by such Selling Holder expressly for inclusion in such document (all of which information is set forth on Schedule I hereto; for purposes of this
Section 2.14(b), any information relating to any underwriter that is contained in a Registration Statement or Prospectus shall not be deemed to be information relating to a Registration Indemnitee), or (ii) a Delivery Failure (other than
any Delivery Failure related to an Underwritten Offering); provided, that no Selling Holder will be liable to any Person who participates as an underwriter in any underwritten offering or sale of Registrable Securities or any other Person, if
any, who controls such underwriter within the meaning of the Securities Act, under the indemnity agreement in this Section 2.14 with respect to any preliminary Prospectus or the final Prospectus (including any amended or supplemented
preliminary or final Prospectus), as the case may be, to the extent that any such loss, claim, damage or liability of such underwriter or controlling Person results from the fact that such underwriter sold Registrable Securities to a Person to whom
there was not sent or given, at or prior to the written confirmation of such sale, a copy of the final Prospectus as then amended or supplemented, whichever is most recent, if the Company has previously furnished copies thereof to such underwriter
and such final Prospectus, as then amended or supplemented, has corrected any such misstatement or omission. Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of the Company or any of its
directors, officers or controlling Persons. The Company may require as a condition to its including Registrable Securities in any Registration Statement filed hereunder that the holder thereof acknowledge its agreement to be bound by the provisions
of this Agreement (including this Section 2.14) applicable to it. 
 (c) Conduct of Indemnification
Proceedings. If any Person shall be entitled to indemnity hereunder (an “indemnified party”), such indemnified party shall give prompt notice to the party from which such indemnity is sought (the “indemnifying
party”) of any claim or of the commencement of any Action with respect to which such indemnified party seeks indemnification or contribution pursuant hereto; provided, however, that the delay or failure to so notify the
indemnifying party shall not relieve the indemnifying party from any obligation or liability except to the extent that the indemnifying party has been actually prejudiced by such delay or failure. The indemnifying party shall have the right,
exercisable by giving written notice to an indemnified party promptly after the receipt of written notice from such indemnified party of such claim or Action, to assume, at the indemnifying party’s expense, the defense of any such Action, with
counsel reasonably satisfactory to such indemnified party; provided, however, that an indemnified party shall have the right to employ separate counsel in any such Action and to participate in the defense thereof, but the fees and
expenses of such counsel shall be at the expense of such indemnified party unless: (i) the indemnifying party agrees to pay such fees and expenses; (ii) the indemnifying party fails promptly to assume, or in the event of a conflict of
interest cannot assume, the defense of such Action or fails to employ counsel reasonably satisfactory to such indemnified party, in which case the indemnified party shall also have the right to employ counsel and to assume the defense of such
Action; or (iii) in the indemnified party’s reasonable judgment a conflict of interest between such indemnified and indemnifying parties may exist in respect of such Action; provided, further, however, that the
indemnifying party shall not, in connection with any one such Action or separate but substantially similar or related Actions in the same jurisdiction, arising out of the same general allegations or circumstances, be liable for the fees and expenses
of more than one firm of attorneys (together with appropriate 
  

 18 

 
local counsel) at any time for all of the indemnified parties, or for fees and expenses that are not reasonable. Whether or not such defense is assumed by the indemnifying party, such indemnified
party will not be subject to any liability for any settlement made without its consent (but such consent will not be unreasonably withheld or delayed). The indemnifying party shall not consent to entry of any judgment or enter into any settlement
that does not include as an unconditional term thereof the giving by all claimants or plaintiffs to such indemnified party of a release, in form and substance reasonably satisfactory to the indemnified party, from all liability in respect of such
claim or litigation. 
 (d) Contribution. 

(i) If the indemnification provided for in this Section 2.14 is unavailable to an indemnified party in respect of any Losses
(other than in accordance with its terms), then each applicable indemnifying party, in lieu of indemnifying such indemnified party, shall contribute to the amount paid or payable by such indemnified party as a result of such Losses, in such
proportion as is appropriate to reflect the relative fault of the indemnifying party, on the one hand, and such indemnified party, on the other hand, in connection with the actions, statements or omissions that resulted in such Losses as well as any
other relevant equitable considerations. The relative fault of such indemnifying party, on the one hand, and indemnified party, on the other hand, shall be determined by reference to, among other things, whether any action in question, including any
untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact, has been taken by, or relates to information supplied by, such indemnifying party or indemnified party, and the parties’ relative
intent, knowledge, access to information and opportunity to correct or prevent any such action, statement or omission. 
 (ii)
The parties hereto agree that it would not be just and equitable if contribution pursuant to this Section 2.14(d) were determined by pro rata allocation or by any other method of allocation that does not take account of the equitable
considerations referred to in the immediately preceding paragraph. 
 (iii) No Person guilty of fraudulent misrepresentation
(within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any Person who was not guilty of such fraudulent misrepresentation. 

(iv) The obligation of any Selling Holder obliged to make contribution pursuant to this Section 2.14(d) shall be several and
not joint. 
 (e) Additional Provisions. 

(i) Notwithstanding anything to the contrary contained in this Agreement, an indemnifying party that is a Holder shall not be required
to indemnify or contribute any amount in excess of the amount by which the net proceeds from the sale of the Registrable Securities sold by such Holder in the applicable offering exceeds the amount of any damages that such Holder has otherwise been
required to pay pursuant to Section 2.14(b). 
 (ii) The indemnification provided for under this Agreement shall
remain in full force and effect regardless of any investigation made by or on behalf of the indemnified party or any officer, director, manager, partner or controlling Person of such indemnified party and shall survive the transfer of securities.

  

 19 

 (iii) The indemnification and contribution required by this Section 2.14 shall
be made by periodic payments of the amount thereof during the course of the investigation or defense, as and when bills are received or Loss is incurred. 

(iv) To the extent that any of the Selling Holders is, or would be expected to be, deemed to be an underwriter of Registrable Securities
pursuant to any SEC comments or policies or any court of law or otherwise, the Company agrees that (i) the indemnification and contribution provisions contained in this Section 2.14 shall be applicable to the benefit of the Selling
Holders in their role as deemed underwriter in addition to their capacity as a Selling Holder (so long as the amount for which any other Selling Holder is or becomes responsible does not exceed the amount for which such Selling Holder would be
responsible if the Selling Holder were not deemed to be an underwriter of Registrable Securities) and (ii) the Selling Holders and their representatives shall be entitled to conduct the due diligence which they would normally conduct in
connection with an offering of securities registered under the Securities Act, including receipt of customary opinions and comfort letters. 

ARTICLE III 

MISCELLANEOUS 

Section 3.1. Other Activities; Nature of Holder Obligations . (a) Notwithstanding anything in this Agreement, none of the
provisions of this Agreement shall in any way limit a Holder or any of its Affiliates from engaging in any brokerage, investment advisory, financial advisory, anti-raid advisory, principaling, merger advisory, financing, asset management, trading,
market making, arbitrage, investment activity and other similar activities conducted in the ordinary course of their business. 

(b) Nature of Holders’ Obligations. The obligations of each Holder under this Agreement are several and not
joint with the obligations of any other Holder, and no Holder shall be responsible in any way for the performance of the obligations of any other Holder under this Agreement, other than as expressly set forth herein. Nothing contained herein, and no
action taken by any Holder pursuant hereto or in connection herewith, shall be deemed to constitute the Holders as a partnership, a joint venture or any other kind of entity, or create a presumption that the Holders are in any way acting in concert
or as a group with respect to such obligations or any of the transactions contemplated by this Agreement. 
 Section 3.2.
Adjustments Affecting Registrable Securities. The Company shall not take any action, or permit any change to occur, with respect to its securities which would adversely affect the ability of any Holder of Registrable Securities to include
such Registrable Securities in a registration undertaken pursuant to this Agreement. 
  

 20 

 Section 3.3. Termination . This Agreement shall terminate upon such time as there are
no Registrable Securities, except for the provisions of Sections 2.7, 2.14 and this Article III, which shall survive such termination. 

Section 3.4. Amendment and Waiver. If any member of the Citi Affiliated Group owns Registrable Securities, no amendment to or
waiver of any provision in this Agreement will be effected without the written consent of Citi if such amendment or waiver adversely affects the rights of any member of the Citi Affiliated Group hereunder. If Warburg or any of its affiliates owns
Registrable Securities, no amendment to or waiver of any provision in this Agreement will be effected without the written consent of Warburg if such amendment or waiver adversely affects the rights of Warburg or any of its Affiliates (excluding
Primerica) hereunder. The failure of any party to enforce any of the provisions of this Agreement shall in no way be construed as a waiver of such provisions and shall not affect the right of such party thereafter to enforce each and every provision
of this Agreement in accordance with its terms. 
 Section 3.5. Severability. If any provision of this Agreement shall be
declared by any court of competent jurisdiction to be illegal, void or unenforceable, all other provisions of this Agreement shall not be affected and shall remain in full force and effect. 

Section 3.6. Entire Agreement. Except as otherwise expressly set forth herein, this Agreement, the Purchase Agreement and the
Intercompany Agreement, together with the several agreements and other documents and instruments referred to herein or therein or annexed hereto or thereto, embody the complete agreement and understanding among the parties hereto with respect to the
subject matter hereof and supersede and preempt any understandings, agreements or representations by or among the parties, written or oral, prior to the date this agreement is first executed by Citi that may have related to the subject matter hereof
in any way. 
 Section 3.7. Counterparts; Execution by Facsimile Signature. This Agreement may be executed in any number
of counterparts, each of which shall be an original, but all of which together shall constitute one instrument. This Agreement may be executed by facsimile signature(s). 

Section 3.8. Remedies. (a) Each party hereto acknowledges that monetary damages would not be an adequate remedy in the event
that any of the covenants or agreements in this Agreement is not performed in accordance with its terms, and it is therefore agreed that, in addition to and without limiting any other remedy or right it may have, the non-breaching party will have
the right to seek an injunction, temporary restraining order or other equitable relief in any court of competent jurisdiction enjoining any such breach or threatened breach and enforcing specifically the terms and provisions hereof. Each party
hereto agrees not to oppose the granting of such relief in the event a court determines that such a breach has occurred, and to waive any requirement for the securing or posting of any bond in connection with such remedy. 

(b) All rights, powers and remedies provided under this Agreement or otherwise available in respect hereof at law or in
equity shall be cumulative and not alternative, and the exercise or beginning of the exercise of any thereof by any party shall not preclude the simultaneous or later exercise of any other such right, power or remedy by such party. 

 

 21 

 Section 3.9. Notices. All notices required or permitted hereunder shall be in writing
and shall be deemed effectively given (i) upon personal delivery to the party to be notified, (ii) when sent by confirmed facsimile if sent during normal business hours of the recipient, if not, then on the next Business Day or
(iii) one Business Day after deposit with a nationally recognized overnight courier, specifying next day delivery, with written verification of receipt. All communications shall be sent to the addresses set forth below or such other address or
facsimile number as a party may from time to time specify by notice to the other parties hereto: 
 If to the Company:

  

	
	 Primerica, Inc.
 3120
Breckinridge Blvd.
 Duluth, Georgia 30099

Attn: General Counsel
 Facsimile:
(770) 564-6216.

 If to any member of the Citi Affiliated Group: 

 

			
	Citigroup Inc.
	399 Park Avenue
	New York, NY 10022
	Attn:	 	Michael Zuckert
		 	Deputy General Counsel and Managing Director
	Facsimile: (212) 793-6300

with copies (which shall not constitute notice) to: 
  

			
	Skadden, Arps, Slate, Meagher & Flom LLP
	4 Times Square New York,
	New York 10036
	Attn:	 	Gregory A. Fernicola
		 	Jeffrey A. Brill
	Facsimile: (212) 735-2000

If to Warburg: 
  

			
	Warburg Pincus Equity Partners, L.P.
	450 Lexington Avenue
	New York, New York 10017-3911
	Attention:	 	Michael E. Martin
		 	Daniel Zilberman
	Facsimile: (212) 716-8626

  

 22 

 with a copy to (which copy alone shall not constitute notice): 

 

			
	Wachtell, Lipton, Rosen & Katz
	51 West 52nd Street
	New York, New York 10019-6150
	Attention:	 	Edward D. Herlihy
		 	David K. Lam
	Facsimile:	 	(212) 403-2000

 Section 3.10.
Governing Law; WAIVER OF JURY TRIAL. This Agreement will be governed by and construed in accordance with the laws of the State of New York applicable to contracts made and to be performed entirely within such State and without
regard to its conflict of laws principles, other than Section 5-1401 of the New York General Obligations Law. The parties hereby irrevocably and unconditionally consent to submit to the exclusive jurisdiction of the state and federal courts
located in the State of New York for any actions, suits or proceedings arising out of or relating to this Agreement and the transactions contemplated hereby. Each of the parties hereby agrees not to commence any such action, suit or proceeding other
than before one of the above-named courts. TO THE FULLEST EXTENT PERMITTED BY LAW, EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATED TO THIS AGREEMENT OR THE
TRANSACTIONS CONTEMPLATED HEREBY AND AGREE THAT ANY SUCH LEGAL PROCEEDING WILL INSTEAD BE TRIED IN A COURT OF COMPETENT JURISDICTION BY A JUDGE SITTING WITHOUT A JURY 

Section 3.11. Condition to Effectiveness for Warburg. Warburg shall not have any rights or obligations under this Agreement until
the closing of the sale of the securities to Warburg pursuant to the Purchase Agreement; neither Citi nor Primerica shall have any obligations to Warburg under this Agreement until such date; and any provisions relating to Warburg in this Agreement
shall be inoperative until such date. 
  

 23 

 IN WITNESS WHEREOF, the parties hereto have executed this Registration Rights Agreement as
of the date first written above. 
  

					
	PRIMERICA, INC.
		
	By:	 	 /s/ Peter W. Schneider

		 	Name:	 	Peter W. Schneider
		 	Title:	 	Executive VP and Secretary

  

					
	 CITIGROUP INSURANCE HOLDING CORPORATION

		
	By:	 	 /s/ John Gerspach

		 	Name:	 	John Gerspach
		 	Title:	 	President

	
	 WARBURG PINCUS PRIVATE EQUITY X, L.P.

	
	 By: Warburg Pincus X L.P., its general

  partner

	 By: Warburg Pincus X LLC, its general

  partner

	 By: Warburg Pincus Partners LLC, its

  sole member

	 By: Warburg Pincus & Co., its managing

  member

  

					
	 By:
	 	/s/ Daniel Zilberman
		 	 Name:
	 	Daniel Zilberman
		 	 Title:
	 	Managing Director

  

	
	 WARBURG PINCUS X PARTNERS, L.P.

	
	 By: Warburg Pincus X L.P., its general

  partner

	 By: Warburg Pincus X LLC, its general

  partner

	 By: Warburg Pincus Partners LLC, its

  sole member

	 By: Warburg Pincus & Co., its managing

  member

  

					
	By:	 	/s/ Daniel Zilberman
		 	Name:	 	Daniel Zilberman
		 	Title:	 	Managing Director

  

 2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00173-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00173-of-00352.parquet"}]]